Edgewise Therapeutics (EWTX) Institutional Ownership

Of the 190 institutional investors that purchased Edgewise Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Novo Holdings A S ($6.34M), Braidwell LP ($5.21M), Janus Henderson Group PLC ($3.73M), Paradigm Biocapital Advisors LP ($2.10M), Morgan Stanley ($2.04M), First Light Asset Management LLC ($2.01M), and UBS Group AG ($2.00M).

Institutional investors have bought a total of 23,177,712 shares in the last 24 months. This purchase volume represents approximately $468.81M in transactions.

Of the 65 institutional investors that sold Edgewise Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Perceptive Advisors LLC ($2.44M), Deerfield Management Company L.P. ($1.30M), First Light Asset Management LLC ($1.01M), Woodline Partners LP ($872.67K), Baker BROS. Advisors LP ($730K), Cormorant Asset Management LP ($725K), and Artisan Partners Limited Partnership ($674.99K).

Institutional investors have sold a total of 11,626,620 shares in the last 24 months. This volume of shares sold represents approximately $220.92M in transactions.